Homburger advised BlueVoyant on the deal, while Bär & Karrer advised ELCA. The American cybersecurity service provider Bluevoyant and the Swiss IT provider ELCA announced the creation...
BlueVoyant’s Cyber-Defense Joint Venture With Elca
Coinbase’s Acquihire of BRD
Homburger acted as Swiss counsel to Coinbase. Coinbase (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the cryptoeconomy, announced its acquihire of BRD,...
FNZ’s Acquisition of Appway
Bär & Karrer acts as legal advisor to the founding shareholders of Appway in this transaction. Goodwin Procter advised Summit Partners. Homburger advised FNZ in this...
CSL’s A$16.4 Billion Acquisition of Vifor Pharma
Homburger AG, Bär & Karrer, Simpson Thacher & Bartlett LLP, and Allens acted as joint legal advisors to CSL. PJT Partners, BofA Securities and Goldman Sachs...
KKR’s Investment in Biosynth Carbosynth
Sidley, Homburger and Wolf Theiss advised KKR on the deal. Bär & Karrer acts as legal advisor to Armira and Dr. Urs Spitz in this transaction....
anthera Pharmaceuticals’ CHF 15 Million Private Convertible Bonds And CHF 10 Million Exchangeable Notes
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of...
Santhera Pharmaceuticals’ CHF 20 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...
On Holding AG’s Initial Public Offering at NYSE
Lenz & Staehelin advised On Holding AG on the deal. Homburger advised the underwriters. On Holding AG, a Swiss-based athletic shoe and performance sportswear company, successfully...
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares...
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...
Santhera Pharmaceuticals Holding AG’s First Exchange Offer For a Convertible Bond
Homburger acted as transaction counsel to Santhera in this matter. Santhera Pharmaceuticals Holding AG announced the settlement of the first exchange offer for a convertible bond...
Picanol NV’s Acquisition of Minority Stake in Rieter Holding AG
Homburger advised Picanol NV on the deal. the diversified industrial group Picanol NV announced that it has acquired 10% of the share capital of Rieter Holding...